TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer

Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas / Sting -deficient male mice, we report that the...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 15; no. 1; pp. 6 - 21
Main Authors Lv, Hongwei, Zong, Qianni, Chen, Cian, Lv, Guishuai, Xiang, Wei, Xing, Fuxue, Jiang, Guoqing, Yan, Bing, Sun, Xiaoyan, Ma, Yue, Wang, Liang, Wu, Zixin, Cui, Xiuliang, Wang, Hongyang, Yang, Wen
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 04.01.2024
Nature Publishing Group
Nature Portfolio
Subjects
13
14
38
42
42/89
59
59/5
631/67/1059/2325
631/67/1504/1610/4029
631/67/2328
64
64/60
96
Anticancer properties
Antitumor agents
Ascorbic acid
Crosstalk
Effectiveness
Endothelial cells
Humanities and Social Sciences
Immune response
Immune system
Immunity
Immunotherapy
In vivo methods and tests
Interleukin 2
Leukocyte migration
Liver cancer
Lymphocytes
Males
Microenvironments
multidisciplinary
PD-L1 protein
Science
Science (multidisciplinary)
Tumors
Online AccessGet full text

Cover

Abstract Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas / Sting -deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer. Activation of the cGAS-STING pathway has been associated with the promotion of anti-tumor immunity. Here the authors show that TET2 upregulates tumor cGAS to activate STING in endothelial cells, inducing tumor vascular normalization and enhancing efficacy of anti-PD-L1 alone or combined with IL-2 in liver cancer preclinical models.
AbstractList Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas / Sting -deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer. Activation of the cGAS-STING pathway has been associated with the promotion of anti-tumor immunity. Here the authors show that TET2 upregulates tumor cGAS to activate STING in endothelial cells, inducing tumor vascular normalization and enhancing efficacy of anti-PD-L1 alone or combined with IL-2 in liver cancer preclinical models.
Abstract Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas/Sting-deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.
Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas/Sting-deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.Activation of the cGAS-STING pathway has been associated with the promotion of anti-tumor immunity. Here the authors show that TET2 upregulates tumor cGAS to activate STING in endothelial cells, inducing tumor vascular normalization and enhancing efficacy of anti-PD-L1 alone or combined with IL-2 in liver cancer preclinical models.
Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas / Sting -deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.
Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas/Sting-deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.
Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas/Sting-deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its role in tumor vasculature is unclear. Herein, using preclinical liver cancer models in Cgas/Sting-deficient male mice, we report that the interdependence between tumor cGAS and host STING mediates vascular normalization and anti-tumor immune response. Mechanistically, TET2 mediated IL-2/STAT5A signaling epigenetically upregulates tumor cGAS expression and produces cGAMP. Subsequently, cGAMP is transported via LRRC8C channels to activate STING in endothelial cells, enhancing recruitment and transendothelial migration of lymphocytes. In vivo studies in male mice also reveal that administration of vitamin C, a promising anti-cancer agent, stimulates TET2 activity, induces tumor vascular normalization and enhances the efficacy of anti-PD-L1 therapy alone or in combination with IL-2. Our findings elucidate a crosstalk between tumor and vascular endothelial cells in the tumor immune microenvironment, providing strategies to enhance the efficacy of combinational immunotherapy for liver cancer.
ArticleNumber 6
Author Ma, Yue
Wu, Zixin
Yang, Wen
Xing, Fuxue
Lv, Hongwei
Xiang, Wei
Cui, Xiuliang
Wang, Hongyang
Jiang, Guoqing
Sun, Xiaoyan
Chen, Cian
Lv, Guishuai
Yan, Bing
Wang, Liang
Zong, Qianni
Author_xml – sequence: 1
  givenname: Hongwei
  surname: Lv
  fullname: Lv, Hongwei
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 2
  givenname: Qianni
  surname: Zong
  fullname: Zong, Qianni
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University)
– sequence: 3
  givenname: Cian
  surname: Chen
  fullname: Chen, Cian
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University)
– sequence: 4
  givenname: Guishuai
  surname: Lv
  fullname: Lv, Guishuai
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University)
– sequence: 5
  givenname: Wei
  surname: Xiang
  fullname: Xiang, Wei
  organization: Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 6
  givenname: Fuxue
  surname: Xing
  fullname: Xing, Fuxue
  organization: Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 7
  givenname: Guoqing
  surname: Jiang
  fullname: Jiang, Guoqing
  organization: Department of Hepatobiliary Surgery, Clinical Medical College, Yangzhou University
– sequence: 8
  givenname: Bing
  surname: Yan
  fullname: Yan, Bing
  organization: Department of Hepatobiliary Surgery, Clinical Medical College, Yangzhou University
– sequence: 9
  givenname: Xiaoyan
  surname: Sun
  fullname: Sun, Xiaoyan
  organization: Hospital of Zhengzhou University
– sequence: 10
  givenname: Yue
  surname: Ma
  fullname: Ma, Yue
  organization: Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 11
  givenname: Liang
  surname: Wang
  fullname: Wang, Liang
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University)
– sequence: 12
  givenname: Zixin
  surname: Wu
  fullname: Wu, Zixin
  organization: Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
– sequence: 13
  givenname: Xiuliang
  surname: Cui
  fullname: Cui, Xiuliang
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University)
– sequence: 14
  givenname: Hongyang
  orcidid: 0000-0002-4709-3334
  surname: Wang
  fullname: Wang, Hongyang
  email: hywangk@vip.sina.com
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education
– sequence: 15
  givenname: Wen
  surname: Yang
  fullname: Yang, Wen
  email: woodeasy66@hotmail.com
  organization: International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Hospital, Naval Medical University (Second Military Medical University), National Center for Liver Cancer, Naval Medical University (Second Military Medical University), Cancer Research Center, First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Shanghai Key Laboratory of Hepato-biliary Tumor Biology, Key Laboratory of Signaling Regulation and Targeting Therapy of Liver Cancer, Ministry of Education
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38177099$$D View this record in MEDLINE/PubMed
BookMark eNp9Uk1v3CAQRVWqJk3zB3qokHrpxS0Y_MExitLtSlF7yPaMMIxdVjakgFfKT8i_Ll6naZVDkBAjeO_NMPPeohPnHSD0npLPlLD2S-SU101BSlZw1nBWiFforCScFrQp2cl_8Sm6iHFP8mKCtpy_QaespU1DhDhDD7vrXVlMYKxKYHCaJx-w3lze4hTsMECIGJzx6ReMVo34drf9vsFKJ3tQyXqHk8cBhnnMbHxQUS_RHCBfTt5kjhuwcibvZItV3E7T7Gy6x9bh0R4gp1NOQ3iHXvdqjHDxeJ6jn1-vd1ffipsfm-3V5U2heVulItfdU6LB1KVQjApmwHAQRqu6EZyVTNQdMYZxUfWdZiq_lNAJaGrSNR3t2DnarrrGq728C3ZS4V56ZeXxwodBqpCsHkHWfV3ntqmGqorzVrSs73MXTcc7w8qqz1qfVq274H_PEJOcbNQwjsqBn6MsBc0dZ7QlGfrxGXTv5-DyTxcUIbyuqgX14RE1d3koT-X9HVgGlCtABx9jgP4JQolcjCFXY8hsDHk0hlxI7TOStuk4vxSUHV-mspUacx6X_fCv7BdYfwD9dcyq
CitedBy_id crossref_primary_10_1039_D4NR04944F
crossref_primary_10_1016_j_biomaterials_2025_123100
crossref_primary_10_1093_bib_bbae686
crossref_primary_10_3389_fimmu_2024_1482728
crossref_primary_10_1016_j_phymed_2025_156562
crossref_primary_10_3389_fimmu_2025_1539396
crossref_primary_10_1111_cas_16420
crossref_primary_10_1016_j_foodchem_2024_142540
crossref_primary_10_1186_s40164_024_00543_1
crossref_primary_10_1016_j_pccm_2024_11_001
crossref_primary_10_1038_s41577_024_01112_7
crossref_primary_10_1186_s12964_024_01983_2
crossref_primary_10_1016_j_intimp_2024_112556
crossref_primary_10_1016_j_intimp_2024_113447
crossref_primary_10_1021_acsomega_4c10865
crossref_primary_10_1016_j_ijbiomac_2024_136580
crossref_primary_10_3892_or_2024_8848
crossref_primary_10_1021_jacs_4c04840
crossref_primary_10_1016_j_canlet_2025_217544
crossref_primary_10_1158_1055_9965_EPI_24_1342
crossref_primary_10_1016_j_canlet_2024_217410
crossref_primary_10_1007_s12094_024_03478_5
crossref_primary_10_1016_j_imbio_2025_152893
crossref_primary_10_4251_wjgo_v17_i2_98556
crossref_primary_10_1007_s12094_024_03726_8
crossref_primary_10_3389_fimmu_2024_1460282
crossref_primary_10_1016_j_fbio_2024_104605
Cites_doi 10.1038/nrg1655
10.1172/JCI67008
10.1016/j.cell.2017.01.017
10.1158/2326-6066.CIR-19-0229
10.1021/acscentsci.1c00440
10.1016/j.celrep.2015.04.031
10.1159/000515305
10.1158/0008-5472.CAN-14-2458
10.1172/JCI125413
10.1016/j.jhep.2019.09.025
10.1007/s00281-014-0419-7
10.1038/s41586-022-05257-0
10.1073/pnas.1512832112
10.1002/ijc.31216
10.3322/caac.21660
10.1038/nrd2130
10.1038/s41388-017-0120-0
10.1126/scitranslmed.aay8707
10.1158/2159-8290.CD-19-0761
10.1016/j.celrep.2014.08.074
10.1016/j.immuni.2013.08.004
10.1016/j.molcel.2020.10.021
10.1016/j.jhep.2008.01.008
10.1161/ATVBAHA.117.309017
10.1016/j.ccell.2016.10.018
10.1038/nature18268
10.1136/jitc-2020-001906
10.1002/hep.27665
10.1038/nature21724
10.15252/msb.20209682
10.1093/nar/gkaa407
10.1073/pnas.1908158117
10.1146/annurev.immunol.26.021607.090357
10.1038/s41568-019-0135-7
10.1016/j.immuni.2020.03.016
10.1002/jlb.67.6.825
10.1016/j.cmet.2020.10.021
10.1158/2159-8290.CD-20-0913
10.1002/hep.30146
10.1016/j.celrep.2015.03.041
10.1093/nar/gkz830
10.1126/science.1260419
10.1146/annurev-physiol-020518-114700
10.1038/nrclinonc.2018.9
10.1016/j.immuni.2015.07.017
10.1016/j.celrep.2015.12.029
10.1016/j.immuni.2020.02.002
10.1016/j.molcel.2019.05.006
10.1093/nar/gkx1090
10.1016/j.cell.2017.07.032
10.1038/nri.2017.145
10.1172/JCI96582
10.1098/rsos.181006
10.1073/pnas.0911267106
10.3390/cancers13112695
10.1158/1078-0432.CCR-15-1362
10.1172/JCI129317
10.1038/nature08476
10.1016/j.omtn.2018.11.003
10.1038/nature23876
10.1016/j.coi.2022.01.004
10.1126/science.1232458
10.3390/antiox7070089
ContentType Journal Article
Copyright The Author(s) 2024
2024. The Author(s).
The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2024
– notice: 2024. The Author(s).
– notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
NPM
3V.
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7X7
7XB
88E
8AO
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ARAPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
LK8
M0S
M1P
M7P
P5Z
P62
P64
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
RC3
SOI
7X8
DOA
DOI 10.1038/s41467-023-43743-9
DatabaseName Springer Nature OA Free Journals
CrossRef
PubMed
ProQuest Central (Corporate)
Bacteriology Abstracts (Microbiology B)
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Ecology Abstracts
Entomology Abstracts (Full archive)
Environment Abstracts
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Technology collection
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection (ProQuest)
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni)
Medical Database
Biological Science Database
Advanced Technologies & Aerospace Database
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
Genetics Abstracts
Environment Abstracts
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
Oncogenes and Growth Factors Abstracts
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
Chemoreception Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Advanced Technologies & Aerospace Collection
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Entomology Abstracts
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Engineering Research Database
ProQuest One Academic
Calcium & Calcified Tissue Abstracts
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
AIDS and Cancer Research Abstracts
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Immunology Abstracts
Environment Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

Publicly Available Content Database
CrossRef
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2041-1723
EndPage 21
ExternalDocumentID oai_doaj_org_article_6f66000a71a5448983ff003db4bd325f
38177099
10_1038_s41467_023_43743_9
Genre Journal Article
GrantInformation_xml – fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 82273176, 81902894, 81972779, 81903036, 81830054, 91859205, and 81988101
  funderid: https://doi.org/10.13039/501100001809
– fundername: Chinese National Key Project (2018ZX10723204-006-003), Shanghai Municipal Commission of Education Project (201901070007E00065), and Program of Shanghai Academic Research Leader (23XD1404800)
– fundername: National Natural Science Foundation of China (National Science Foundation of China)
  grantid: 82273176, 81902894, 81972779, 81903036, 81830054, 91859205, and 81988101
GroupedDBID ---
0R~
39C
3V.
53G
5VS
70F
7X7
88E
8AO
8FE
8FG
8FH
8FI
8FJ
AAHBH
AAJSJ
ABUWG
ACGFO
ACGFS
ACIWK
ACMJI
ACPRK
ACSMW
ADBBV
ADFRT
ADMLS
ADRAZ
AENEX
AEUYN
AFKRA
AFRAH
AHMBA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMTXH
AOIJS
ARAPS
ASPBG
AVWKF
AZFZN
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
EBLON
EBS
EE.
EMOBN
F5P
FEDTE
FYUFA
GROUPED_DOAJ
HCIFZ
HMCUK
HVGLF
HYE
HZ~
KQ8
LGEZI
LK8
LOTEE
M1P
M48
M7P
M~E
NADUK
NAO
NXXTH
O9-
OK1
P2P
P62
PIMPY
PQQKQ
PROAC
PSQYO
RNS
RNT
RNTTT
RPM
SNYQT
SV3
TSG
UKHRP
AASML
AAYXX
CITATION
PHGZM
PHGZT
NPM
PJZUB
PPXIY
PQGLB
7QL
7QP
7QR
7SN
7SS
7ST
7T5
7T7
7TM
7TO
7XB
8FD
8FK
AARCD
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
P64
PKEHL
PQEST
PQUKI
RC3
SOI
7X8
PUEGO
ID FETCH-LOGICAL-c485t-770f10ced629a3193ded4e9dca679432396b0dd3495fbc3a9dc2eb9e760b7b1b3
IEDL.DBID M48
ISSN 2041-1723
IngestDate Wed Aug 27 01:30:19 EDT 2025
Fri Jul 11 15:17:00 EDT 2025
Wed Aug 13 03:25:54 EDT 2025
Mon Jul 21 06:02:38 EDT 2025
Thu Apr 24 22:50:29 EDT 2025
Tue Jul 01 02:10:52 EDT 2025
Fri Feb 21 02:37:34 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License 2024. The Author(s).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c485t-770f10ced629a3193ded4e9dca679432396b0dd3495fbc3a9dc2eb9e760b7b1b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-4709-3334
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41467-023-43743-9
PMID 38177099
PQID 2910046550
PQPubID 546298
PageCount 21
ParticipantIDs doaj_primary_oai_doaj_org_article_6f66000a71a5448983ff003db4bd325f
proquest_miscellaneous_2911843180
proquest_journals_2910046550
pubmed_primary_38177099
crossref_primary_10_1038_s41467_023_43743_9
crossref_citationtrail_10_1038_s41467_023_43743_9
springer_journals_10_1038_s41467_023_43743_9
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-04
PublicationDateYYYYMMDD 2024-01-04
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-04
  day: 04
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature communications
PublicationTitleAbbrev Nat Commun
PublicationTitleAlternate Nat Commun
PublicationYear 2024
Publisher Nature Publishing Group UK
Nature Publishing Group
Nature Portfolio
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
– name: Nature Portfolio
References Nauman, Gray, Parkinson, Levine, Paller (CR56) 2018; 7
Lan, Londoño, Bouley, Rooney, Hacohen (CR59) 2014; 9
Falahat (CR42) 2019; 7
Menyhárt, Nagy, Győrffy (CR65) 2018; 5
Chang (CR37) 2018; 142
Chelvanambi, Fecek, Taylor, Storkus (CR45) 2021; 9
Huang (CR4) 2018; 18
Amouzegar, Chelvanambi, Filderman, Storkus, Luke (CR14) 2021; 13
Magrì (CR58) 2020; 12
Xia, Konno, Ahn, Barber (CR52) 2016; 14
Martin, Seano, Jain (CR6) 2019; 81
Guey, Ablasser (CR12) 2022; 74
Wilhelm (CR33) 2006; 5
Gehrke (CR60) 2013; 39
Xu (CR54) 2019; 129
Newell, Villanueva, Friedman, Koike, Llovet (CR39) 2008; 48
Corrales (CR48) 2015; 11
West (CR40) 2013; 123
Agathocleous (CR32) 2017; 549
Cordova, Ritchie, Böhnert, Li (CR23) 2021; 7
Zheng (CR5) 2018; 128
Uhlén (CR61) 2015; 347
Park (CR15) 2016; 30
Chen (CR36) 2015; 61
Slaney, Kershaw, Darcy (CR55) 2014; 74
Mao (CR46) 2017; 37
Huang (CR47) 2020; 52
Corrales, Gajewski (CR13) 2015; 21
Lv (CR53) 2021; 33
Yang (CR28) 2015; 43
Ding (CR63) 2020; 48
Lahey (CR24) 2020; 80
Vasaikar, Straub, Wang, Zhang (CR64) 2018; 46
Khan, Kerbel (CR8) 2018; 15
Demaria (CR49) 2015; 112
Ngo, Riper, Cantley, Yun, Targeting (CR34) 2019; 19
Yang (CR44) 2019; 129
Konno (CR51) 2018; 37
Tian (CR7) 2017; 544
Massalha (CR17) 2020; 16
Sung (CR1) 2021; 71
Shen (CR50) 2015; 11
Ishikawa, Ma, Barber (CR10) 2009; 461
Cheng, Hsu, Chan, Choo, Kudo (CR2) 2020; 72
Lv (CR35) 2018; 2
Hashimoto (CR41) 2022; 610
Li (CR62) 2020; 48
Hsu (CR38) 2021; 10
Saitoh (CR18) 2009; 106
Sun, Wu, Du, Chen, Chen (CR9) 2013; 339
Luchtel (CR57) 2020; 117
Sharma, Hu-Lieskovan, Wargo, Ribas (CR3) 2017; 168
Robertson (CR27) 2005; 6
Vestweber, Wessel, Nottebaum (CR20) 2014; 36
Kwon, Bakhoum (CR11) 2020; 10
Ritchie, Cordova, Hess, Bassik, Li (CR22) 2019; 75
Cimmino (CR31) 2017; 170
Heidenreich, Kappel, Breier (CR16) 2000; 60
Malek (CR29) 2008; 26
Liu (CR30) 2019; 69
Chen (CR21) 2016; 533
Ding, Xiong, Issekutz (CR19) 2000; 67
Zhou (CR25) 2020; 52
An (CR26) 2019; 14
Mahadevan (CR43) 2021; 11
YJ Shen (43743_CR50) 2015; 11
C Ritchie (43743_CR22) 2019; 75
L Corrales (43743_CR13) 2015; 21
H Lv (43743_CR53) 2021; 33
H Sung (43743_CR1) 2021; 71
JS Park (43743_CR15) 2016; 30
H Yang (43743_CR44) 2019; 129
NR Mahadevan (43743_CR43) 2021; 11
AF Cordova (43743_CR23) 2021; 7
M Uhlén (43743_CR61) 2015; 347
W Ding (43743_CR63) 2020; 48
A Amouzegar (43743_CR14) 2021; 13
L Tian (43743_CR7) 2017; 544
LS Huang (43743_CR47) 2020; 52
C Hsu (43743_CR38) 2021; 10
C Zhou (43743_CR25) 2020; 52
CY Slaney (43743_CR55) 2014; 74
M Chelvanambi (43743_CR45) 2021; 9
H Massalha (43743_CR17) 2020; 16
Z Ding (43743_CR19) 2000; 67
B Ngo (43743_CR34) 2019; 19
N Gehrke (43743_CR60) 2013; 39
X An (43743_CR26) 2019; 14
H Konno (43743_CR51) 2018; 37
Y Chen (43743_CR36) 2015; 61
O Menyhárt (43743_CR65) 2018; 5
R Heidenreich (43743_CR16) 2000; 60
KD Robertson (43743_CR27) 2005; 6
R Falahat (43743_CR42) 2019; 7
Y Mao (43743_CR46) 2017; 37
L Corrales (43743_CR48) 2015; 11
H Ishikawa (43743_CR10) 2009; 461
H Lv (43743_CR35) 2018; 2
T Li (43743_CR62) 2020; 48
R Yang (43743_CR28) 2015; 43
J Liu (43743_CR30) 2019; 69
Y Huang (43743_CR4) 2018; 18
TR Malek (43743_CR29) 2008; 26
YY Lan (43743_CR59) 2014; 9
P Sharma (43743_CR3) 2017; 168
P Newell (43743_CR39) 2008; 48
B Guey (43743_CR12) 2022; 74
A Magrì (43743_CR58) 2020; 12
KA Khan (43743_CR8) 2018; 15
M Agathocleous (43743_CR32) 2017; 549
X Zheng (43743_CR5) 2018; 128
RA Luchtel (43743_CR57) 2020; 117
Q Chen (43743_CR21) 2016; 533
T Xia (43743_CR52) 2016; 14
JD Martin (43743_CR6) 2019; 81
L Sun (43743_CR9) 2013; 339
CJ Chang (43743_CR37) 2018; 142
AL Cheng (43743_CR2) 2020; 72
S Wilhelm (43743_CR33) 2006; 5
M Hashimoto (43743_CR41) 2022; 610
O Demaria (43743_CR49) 2015; 112
J Kwon (43743_CR11) 2020; 10
T Saitoh (43743_CR18) 2009; 106
SV Vasaikar (43743_CR64) 2018; 46
D Vestweber (43743_CR20) 2014; 36
L Cimmino (43743_CR31) 2017; 170
YP Xu (43743_CR54) 2019; 129
EE West (43743_CR40) 2013; 123
G Nauman (43743_CR56) 2018; 7
LJ Lahey (43743_CR24) 2020; 80
References_xml – volume: 6
  start-page: 597
  year: 2005
  end-page: 610
  ident: CR27
  article-title: DNA methylation and human disease
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1655
– volume: 123
  start-page: 2604
  year: 2013
  end-page: 2615
  ident: CR40
  article-title: PD-L1 blockade synergizes with IL-2 therapy in reinvigorating exhausted T cells
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI67008
– volume: 168
  start-page: 707
  year: 2017
  end-page: 723
  ident: CR3
  article-title: Primary, adaptive, and acquired resistance to cancer immunotherapy
  publication-title: Cell
  doi: 10.1016/j.cell.2017.01.017
– volume: 7
  start-page: 1837
  year: 2019
  end-page: 1848
  ident: CR42
  article-title: STING signaling in melanoma cells shapes antigenicity and can promote antitumor T-cell activity
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-19-0229
– volume: 7
  start-page: 1073
  year: 2021
  end-page: 1088
  ident: CR23
  article-title: Human SLC46A2 is the dominant cGAMP importer in extracellular cGAMP-sensing macrophages and monocytes
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.1c00440
– volume: 11
  start-page: 1018
  year: 2015
  end-page: 1030
  ident: CR48
  article-title: Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.04.031
– volume: 10
  start-page: 346
  year: 2021
  end-page: 359
  ident: CR38
  article-title: Exploring markers of exhausted CD8 T cells to predict response to immune checkpoint inhibitor therapy for hepatocellular carcinoma
  publication-title: Liver Cancer
  doi: 10.1159/000515305
– volume: 74
  start-page: 7168
  year: 2014
  end-page: 7174
  ident: CR55
  article-title: Trafficking of T cells into tumors
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-14-2458
– volume: 129
  start-page: 4350
  year: 2019
  end-page: 4364
  ident: CR44
  article-title: STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI125413
– volume: 72
  start-page: 307
  year: 2020
  end-page: 319
  ident: CR2
  article-title: Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2019.09.025
– volume: 36
  start-page: 177
  year: 2014
  end-page: 192
  ident: CR20
  article-title: Similarities and differences in the regulation of leukocyte extravasation and vascular permeability
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-014-0419-7
– volume: 610
  start-page: 173
  year: 2022
  end-page: 181
  ident: CR41
  article-title: PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program
  publication-title: Nature
  doi: 10.1038/s41586-022-05257-0
– volume: 112
  start-page: 15408
  year: 2015
  end-page: 15413
  ident: CR49
  article-title: STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1512832112
– volume: 142
  start-page: 1878
  year: 2018
  end-page: 1889
  ident: CR37
  article-title: Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31216
– volume: 71
  start-page: 209
  year: 2021
  end-page: 249
  ident: CR1
  article-title: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
– volume: 5
  start-page: 835
  year: 2006
  end-page: 844
  ident: CR33
  article-title: Discovery and development of sorafenib: a multikinase inhibitor for treating cancer
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2130
– volume: 37
  start-page: 2037
  year: 2018
  end-page: 2051
  ident: CR51
  article-title: Suppression of STING signaling through epigenetic silencing and missense mutation impedes DNA damage mediated cytokine production
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0120-0
– volume: 12
  start-page: eaay8707
  year: 2020
  ident: CR58
  article-title: High-dose vitamin C enhances cancer immunotherapy
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aay8707
– volume: 10
  start-page: 26
  year: 2020
  end-page: 39
  ident: CR11
  article-title: The cytosolic DNA-sensing cGAS-STING pathway in cancer
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-19-0761
– volume: 9
  start-page: 180
  year: 2014
  end-page: 192
  ident: CR59
  article-title: Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.08.074
– volume: 39
  start-page: 482
  year: 2013
  end-page: 495
  ident: CR60
  article-title: Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.08.004
– volume: 80
  start-page: 578
  year: 2020
  end-page: 591
  ident: CR24
  article-title: LRRC8A:C/E heteromeric channels are ubiquitous transporters of cGAMP
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2020.10.021
– volume: 48
  start-page: 858
  year: 2008
  end-page: 879
  ident: CR39
  article-title: Experimental models of hepatocellular carcinoma
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2008.01.008
– volume: 37
  start-page: 920
  year: 2017
  end-page: 929
  ident: CR46
  article-title: STING-IRF3 triggers endothelial inflammation in response to free fatty acid-induced mitochondrial damage in diet-induced obesity
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.117.309017
– volume: 30
  start-page: 953
  year: 2016
  end-page: 967
  ident: CR15
  article-title: Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.10.018
– volume: 533
  start-page: 493
  year: 2016
  end-page: 498
  ident: CR21
  article-title: Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer
  publication-title: Nature
  doi: 10.1038/nature18268
– volume: 9
  start-page: e001906
  year: 2021
  ident: CR45
  article-title: STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2020-001906
– volume: 61
  start-page: 1591
  year: 2015
  end-page: 1602
  ident: CR36
  article-title: CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
  publication-title: Hepatology
  doi: 10.1002/hep.27665
– volume: 544
  start-page: 250
  year: 2017
  end-page: 254
  ident: CR7
  article-title: Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
  publication-title: Nature
  doi: 10.1038/nature21724
– volume: 16
  start-page: e9682
  year: 2020
  ident: CR17
  article-title: A single cell atlas of the human liver tumor microenvironment
  publication-title: Mol. Syst. Biol.
  doi: 10.15252/msb.20209682
– volume: 48
  start-page: W509
  year: 2020
  end-page: W514
  ident: CR62
  article-title: TIMER2.0 for analysis of tumor-infiltrating immune cells
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa407
– volume: 117
  start-page: 1666
  year: 2020
  end-page: 1677
  ident: CR57
  article-title: High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1908158117
– volume: 26
  start-page: 453
  year: 2008
  end-page: 479
  ident: CR29
  article-title: The biology of interleukin-2
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.26.021607.090357
– volume: 2
  start-page: 1
  year: 2018
  ident: CR35
  article-title: Vitamin C preferentially kills cancer stem cells in hepatocellular carcinoma via SVCT-2.
  publication-title: Oncol
– volume: 19
  start-page: 271
  year: 2019
  end-page: 282
  ident: CR34
  article-title: cancer vulnerabilities with high-dose vitamin C
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0135-7
– volume: 52
  start-page: 767
  year: 2020
  end-page: 781
  ident: CR25
  article-title: Transfer of cGAMP into Bystander cells via LRRC8 volume-regulated anion channels augments STING-mediated interferon responses and anti-viral immunity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.03.016
– volume: 67
  start-page: 825
  year: 2000
  end-page: 833
  ident: CR19
  article-title: Regulation of chemokine-induced transendothelial migration of T lymphocytes by endothelial activation: differential effects on naive and memory T cells
  publication-title: J. Leukoc. Biol.
  doi: 10.1002/jlb.67.6.825
– volume: 33
  start-page: 110
  year: 2021
  end-page: 127.e5
  ident: CR53
  article-title: NAD+ metabolism maintains inducible PD-L1 expression to drive tumor immune evasion
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2020.10.021
– volume: 60
  start-page: 6142
  year: 2000
  end-page: 6147
  ident: CR16
  article-title: Tumor endothelium-specific transgene expression directed by vascular endothelial growth factor receptor-2 (Flk-1) promoter/enhancer sequences
  publication-title: Cancer Res.
– volume: 11
  start-page: 1952
  year: 2021
  end-page: 1969
  ident: CR43
  article-title: Intrinsic immunogenicity of small cell lung carcinoma revealed by its cellular plasticity
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-20-0913
– volume: 69
  start-page: 196
  year: 2019
  end-page: 208
  ident: CR30
  article-title: Global DNA 5-hydroxymethylcytosine and 5-formylcytosine contents are decreased in the early stage of hepatocellular carcinoma
  publication-title: Hepatology
  doi: 10.1002/hep.30146
– volume: 11
  start-page: 460
  year: 2015
  end-page: 473
  ident: CR50
  article-title: Genome-derived cytosolic DNA mediates type I interferon-dependent rejection of B cell lymphoma cells
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.03.041
– volume: 48
  start-page: D856
  year: 2020
  end-page: D862
  ident: CR63
  article-title: DNMIVD: DNA methylation interactive visualization database
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz830
– volume: 347
  start-page: 1260419
  year: 2015
  ident: CR61
  article-title: Proteomics. Tissue-based map of the human proteome
  publication-title: Science
  doi: 10.1126/science.1260419
– volume: 81
  start-page: 505
  year: 2019
  end-page: 534
  ident: CR6
  article-title: Normalizing function of tumor vessels: progress, opportunities, and challenges
  publication-title: Annu. Rev. Physiol.
  doi: 10.1146/annurev-physiol-020518-114700
– volume: 15
  start-page: 310
  year: 2018
  end-page: 324
  ident: CR8
  article-title: Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2018.9
– volume: 43
  start-page: 251
  year: 2015
  end-page: 263
  ident: CR28
  article-title: Hydrogen sulfide promotes Tet1- and Tet2-mediated Foxp3 demethylation to drive regulatory T cell differentiation and maintain immune homeostasis
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.07.017
– volume: 14
  start-page: 282
  year: 2016
  end-page: 297
  ident: CR52
  article-title: Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.12.029
– volume: 52
  start-page: 475
  year: 2020
  end-page: 486.e5
  ident: CR47
  article-title: mtDNA activates cGAS signaling and suppresses the YAP-mediated endothelial cell proliferation program to promote inflammatory injury
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.02.002
– volume: 75
  start-page: 372
  year: 2019
  end-page: 381
  ident: CR22
  article-title: SLC19A1 Is an Importer of the Immunotransmitter cGAMP
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2019.05.006
– volume: 46
  start-page: D956
  year: 2018
  end-page: D963
  ident: CR64
  article-title: LinkedOmics: analyzing multi-omics data within and across 32 cancer types
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx1090
– volume: 170
  start-page: 1079
  year: 2017
  end-page: 1095.e20
  ident: CR31
  article-title: Restoration of TET2 function blocks aberrant self-renewal and leukemia progression
  publication-title: Cell
  doi: 10.1016/j.cell.2017.07.032
– volume: 18
  start-page: 195
  year: 2018
  end-page: 203
  ident: CR4
  article-title: Improving immune-vascular crosstalk for cancer immunotherapy
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2017.145
– volume: 128
  start-page: 2104
  year: 2018
  end-page: 2115
  ident: CR5
  article-title: Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI96582
– volume: 5
  start-page: 181006
  year: 2018
  ident: CR65
  article-title: Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
  publication-title: R. Soc. Open Sci.
  doi: 10.1098/rsos.181006
– volume: 106
  start-page: 20842
  year: 2009
  end-page: 20846
  ident: CR18
  article-title: Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0911267106
– volume: 13
  start-page: 2695
  year: 2021
  ident: CR14
  article-title: STING agonists as cancer therapeutics
  publication-title: Cancers
  doi: 10.3390/cancers13112695
– volume: 21
  start-page: 4774
  year: 2015
  end-page: 4779
  ident: CR13
  article-title: Molecular pathways: targeting the stimulator of interferon genes (STING) in the immunotherapy of cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1362
– volume: 129
  start-page: 4316
  year: 2019
  end-page: 4331
  ident: CR54
  article-title: Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI129317
– volume: 461
  start-page: 788
  year: 2009
  end-page: 792
  ident: CR10
  article-title: STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity
  publication-title: Nature
  doi: 10.1038/nature08476
– volume: 14
  start-page: 80
  year: 2019
  end-page: 89
  ident: CR26
  article-title: An analysis of the expression and association with immune cell infiltration of the cGAS/STING pathway in pan-cancer
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2018.11.003
– volume: 549
  start-page: 476
  year: 2017
  end-page: 481
  ident: CR32
  article-title: Ascorbate regulates haematopoietic stem cell function and leukaemogenesis
  publication-title: Nature
  doi: 10.1038/nature23876
– volume: 74
  start-page: 164
  year: 2022
  end-page: 171
  ident: CR12
  article-title: Emerging dimensions of cellular cGAS-STING signaling
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2022.01.004
– volume: 339
  start-page: 786
  year: 2013
  end-page: 791
  ident: CR9
  article-title: Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway
  publication-title: Science
  doi: 10.1126/science.1232458
– volume: 7
  start-page: 89
  year: 2018
  ident: CR56
  article-title: Systematic review of intravenous ascorbate in cancer clinical trials
  publication-title: Antioxidants
  doi: 10.3390/antiox7070089
– volume: 5
  start-page: 181006
  year: 2018
  ident: 43743_CR65
  publication-title: R. Soc. Open Sci.
  doi: 10.1098/rsos.181006
– volume: 461
  start-page: 788
  year: 2009
  ident: 43743_CR10
  publication-title: Nature
  doi: 10.1038/nature08476
– volume: 5
  start-page: 835
  year: 2006
  ident: 43743_CR33
  publication-title: Nat. Rev. Drug Discov.
  doi: 10.1038/nrd2130
– volume: 106
  start-page: 20842
  year: 2009
  ident: 43743_CR18
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0911267106
– volume: 14
  start-page: 282
  year: 2016
  ident: 43743_CR52
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.12.029
– volume: 48
  start-page: D856
  year: 2020
  ident: 43743_CR63
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz830
– volume: 26
  start-page: 453
  year: 2008
  ident: 43743_CR29
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.26.021607.090357
– volume: 11
  start-page: 1018
  year: 2015
  ident: 43743_CR48
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.04.031
– volume: 14
  start-page: 80
  year: 2019
  ident: 43743_CR26
  publication-title: Mol. Ther. Nucleic Acids
  doi: 10.1016/j.omtn.2018.11.003
– volume: 7
  start-page: 89
  year: 2018
  ident: 43743_CR56
  publication-title: Antioxidants
  doi: 10.3390/antiox7070089
– volume: 10
  start-page: 346
  year: 2021
  ident: 43743_CR38
  publication-title: Liver Cancer
  doi: 10.1159/000515305
– volume: 610
  start-page: 173
  year: 2022
  ident: 43743_CR41
  publication-title: Nature
  doi: 10.1038/s41586-022-05257-0
– volume: 33
  start-page: 110
  year: 2021
  ident: 43743_CR53
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2020.10.021
– volume: 129
  start-page: 4350
  year: 2019
  ident: 43743_CR44
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI125413
– volume: 37
  start-page: 920
  year: 2017
  ident: 43743_CR46
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.117.309017
– volume: 72
  start-page: 307
  year: 2020
  ident: 43743_CR2
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2019.09.025
– volume: 81
  start-page: 505
  year: 2019
  ident: 43743_CR6
  publication-title: Annu. Rev. Physiol.
  doi: 10.1146/annurev-physiol-020518-114700
– volume: 7
  start-page: 1073
  year: 2021
  ident: 43743_CR23
  publication-title: ACS Cent. Sci.
  doi: 10.1021/acscentsci.1c00440
– volume: 12
  start-page: eaay8707
  year: 2020
  ident: 43743_CR58
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aay8707
– volume: 7
  start-page: 1837
  year: 2019
  ident: 43743_CR42
  publication-title: Cancer Immunol. Res.
  doi: 10.1158/2326-6066.CIR-19-0229
– volume: 52
  start-page: 475
  year: 2020
  ident: 43743_CR47
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.02.002
– volume: 6
  start-page: 597
  year: 2005
  ident: 43743_CR27
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/nrg1655
– volume: 46
  start-page: D956
  year: 2018
  ident: 43743_CR64
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkx1090
– volume: 11
  start-page: 1952
  year: 2021
  ident: 43743_CR43
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-20-0913
– volume: 43
  start-page: 251
  year: 2015
  ident: 43743_CR28
  publication-title: Immunity
  doi: 10.1016/j.immuni.2015.07.017
– volume: 30
  start-page: 953
  year: 2016
  ident: 43743_CR15
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2016.10.018
– volume: 18
  start-page: 195
  year: 2018
  ident: 43743_CR4
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri.2017.145
– volume: 9
  start-page: 180
  year: 2014
  ident: 43743_CR59
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2014.08.074
– volume: 549
  start-page: 476
  year: 2017
  ident: 43743_CR32
  publication-title: Nature
  doi: 10.1038/nature23876
– volume: 39
  start-page: 482
  year: 2013
  ident: 43743_CR60
  publication-title: Immunity
  doi: 10.1016/j.immuni.2013.08.004
– volume: 128
  start-page: 2104
  year: 2018
  ident: 43743_CR5
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI96582
– volume: 36
  start-page: 177
  year: 2014
  ident: 43743_CR20
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-014-0419-7
– volume: 533
  start-page: 493
  year: 2016
  ident: 43743_CR21
  publication-title: Nature
  doi: 10.1038/nature18268
– volume: 71
  start-page: 209
  year: 2021
  ident: 43743_CR1
  publication-title: CA Cancer J. Clin.
  doi: 10.3322/caac.21660
– volume: 9
  start-page: e001906
  year: 2021
  ident: 43743_CR45
  publication-title: J. Immunother. Cancer
  doi: 10.1136/jitc-2020-001906
– volume: 339
  start-page: 786
  year: 2013
  ident: 43743_CR9
  publication-title: Science
  doi: 10.1126/science.1232458
– volume: 74
  start-page: 164
  year: 2022
  ident: 43743_CR12
  publication-title: Curr. Opin. Immunol.
  doi: 10.1016/j.coi.2022.01.004
– volume: 168
  start-page: 707
  year: 2017
  ident: 43743_CR3
  publication-title: Cell
  doi: 10.1016/j.cell.2017.01.017
– volume: 60
  start-page: 6142
  year: 2000
  ident: 43743_CR16
  publication-title: Cancer Res.
– volume: 544
  start-page: 250
  year: 2017
  ident: 43743_CR7
  publication-title: Nature
  doi: 10.1038/nature21724
– volume: 112
  start-page: 15408
  year: 2015
  ident: 43743_CR49
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1512832112
– volume: 19
  start-page: 271
  year: 2019
  ident: 43743_CR34
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/s41568-019-0135-7
– volume: 129
  start-page: 4316
  year: 2019
  ident: 43743_CR54
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI129317
– volume: 10
  start-page: 26
  year: 2020
  ident: 43743_CR11
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-19-0761
– volume: 347
  start-page: 1260419
  year: 2015
  ident: 43743_CR61
  publication-title: Science
  doi: 10.1126/science.1260419
– volume: 13
  start-page: 2695
  year: 2021
  ident: 43743_CR14
  publication-title: Cancers
  doi: 10.3390/cancers13112695
– volume: 142
  start-page: 1878
  year: 2018
  ident: 43743_CR37
  publication-title: Int. J. Cancer
  doi: 10.1002/ijc.31216
– volume: 16
  start-page: e9682
  year: 2020
  ident: 43743_CR17
  publication-title: Mol. Syst. Biol.
  doi: 10.15252/msb.20209682
– volume: 48
  start-page: 858
  year: 2008
  ident: 43743_CR39
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2008.01.008
– volume: 2
  start-page: 1
  year: 2018
  ident: 43743_CR35
  publication-title: Oncol
– volume: 15
  start-page: 310
  year: 2018
  ident: 43743_CR8
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/nrclinonc.2018.9
– volume: 67
  start-page: 825
  year: 2000
  ident: 43743_CR19
  publication-title: J. Leukoc. Biol.
  doi: 10.1002/jlb.67.6.825
– volume: 74
  start-page: 7168
  year: 2014
  ident: 43743_CR55
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-14-2458
– volume: 48
  start-page: W509
  year: 2020
  ident: 43743_CR62
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkaa407
– volume: 61
  start-page: 1591
  year: 2015
  ident: 43743_CR36
  publication-title: Hepatology
  doi: 10.1002/hep.27665
– volume: 21
  start-page: 4774
  year: 2015
  ident: 43743_CR13
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-1362
– volume: 75
  start-page: 372
  year: 2019
  ident: 43743_CR22
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2019.05.006
– volume: 69
  start-page: 196
  year: 2019
  ident: 43743_CR30
  publication-title: Hepatology
  doi: 10.1002/hep.30146
– volume: 37
  start-page: 2037
  year: 2018
  ident: 43743_CR51
  publication-title: Oncogene
  doi: 10.1038/s41388-017-0120-0
– volume: 170
  start-page: 1079
  year: 2017
  ident: 43743_CR31
  publication-title: Cell
  doi: 10.1016/j.cell.2017.07.032
– volume: 52
  start-page: 767
  year: 2020
  ident: 43743_CR25
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.03.016
– volume: 123
  start-page: 2604
  year: 2013
  ident: 43743_CR40
  publication-title: J. Clin. Investig.
  doi: 10.1172/JCI67008
– volume: 11
  start-page: 460
  year: 2015
  ident: 43743_CR50
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2015.03.041
– volume: 117
  start-page: 1666
  year: 2020
  ident: 43743_CR57
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1908158117
– volume: 80
  start-page: 578
  year: 2020
  ident: 43743_CR24
  publication-title: Mol. Cell
  doi: 10.1016/j.molcel.2020.10.021
SSID ssj0000391844
Score 2.6124682
Snippet Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity, but its...
Abstract Induction of tumor vascular normalization is a crucial measure to enhance immunotherapy efficacy. cGAS-STING pathway is vital for anti-tumor immunity,...
SourceID doaj
proquest
pubmed
crossref
springer
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 6
SubjectTerms 13
14
38
42
42/89
59
59/5
631/67/1059/2325
631/67/1504/1610/4029
631/67/2328
64
64/60
96
Anticancer properties
Antitumor agents
Ascorbic acid
Crosstalk
Effectiveness
Endothelial cells
Humanities and Social Sciences
Immune response
Immune system
Immunity
Immunotherapy
In vivo methods and tests
Interleukin 2
Leukocyte migration
Liver cancer
Lymphocytes
Males
Microenvironments
multidisciplinary
PD-L1 protein
Science
Science (multidisciplinary)
Tumors
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlUOilJOnLTVJU6K0VsS1Zto5J2TwKzSUbyE3oZVjYeMOu97A_of86M5J3u6VNesnBF0kWenzSzEiabwj5kntRhNYohnRyTChjmQrKMYW2hCstCCV0FP55JS9uxI_b6nYr1Be-CUv0wGngjmUrQSbnpi5MBaaEanjbAhK9Fdbzsmpx9wWZt2VMxT2YKzBdxOAlk_PmeCHingAiigmOvJzqD0kUCfv_pWX-dUMaBc_ZLnk9aIz0JLV0j7wI3T55mWJIrt6QX-PRuGTRAQSUR9ov72Zz6s5PrmkPhjfUt6Ch8-hnNQWo0evx5dU5RW-GdBZL-xmdp3j0gQ7PUvFSARJjkBxoEjWdh6-fsFT5JLqU9Cs66egUn3VQh9CZvyU3Z6Px9ws2xFdgTjRVD4p13ha5C16WysBS5D54EZR3RiJtXMmVtLn3HGyo1jpuIKcMVoVa5ra2heXvyE4368IHQo3xofGmqnmbC1s5UEOFldyGqglgsvCMFOux1m4gH8cYGFMdL8F5o9P8aJgfHedHq4x83fxzn6g3nix9ilO4KYm02TEBwKQHMOn_gSkjh2sA6GEtL3SpkFVPgimXkc-bbFiFeLViujBbxjIYOKdooMz7BJxNS5ADsQZFPCPf1kj6XfnjHfr4HB06IK9K0MLimZE4JDv9fBmOQIvq7ae4YB4AjhwWCg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkLanmGFmQkbmA1iZ2HT6ig7hYkeulW6s3yK2ilbVKy2UN_Qv91ZxxvKgTtIZfEsZzMjP15xvMNIZ9SJzLfaMmQTo4JqQ2TXlomcS9hcwOLEiYK_zotT87Fz4viIjrc1vFY5XZODBO16yz6yA9zidxmJQDqr1d_GFaNwuhqLKHxmDzJYKXBI131bD75WJD9vBYi5sqkvD5cizAzwELFBEd2TvnXehRo-_-HNf-Jk4blZ7ZLnkfcSI9GQe-RR759QZ6OlSSvX5KbxfEiZyENBCAkHTaXXU_t_OiMDvAN0N-a-tZhttUKFI6eLX6czinmNIweWTp0tB-r0nsaD6diaAFuhlI5MCSqWwfXsGRj58uQWDJc02VLV3i4g1pUoP4VOZ8dL76fsFhlgVlRFwPA67TJUutdmUsNBsmdd8JLZ3WJ5HE5l6VJneOwk2qM5Rqe5N5IX5WpqUxm-Guy03atf0uo1s7XThcVb1JhCgtgVJiSG1_UHjYuPCHZ9l8rGynIsRLGSoVQOK_VKB8F8lFBPkom5PP0ztVIwPFg628owqklkmeHG13_W0VbVGVTAsxLdZXpAnansuZNA7rijDCO50WTkIOtAqho0Wt1p38J-Tg9BlvEAItufbcJbbB8TlZDmzej4kwjQSbECuB4Qr5sNemu8_s_6N3DY9knz3JAWcEnJA7IztBv_HtASYP5EEzhFnkJDi4
  priority: 102
  providerName: ProQuest
– databaseName: Springer Nature HAS Fully OA
  dbid: AAJSJ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELZKKyQuiDeBgozEDSyS2HHi44L6YCV62a3Um-VX0EpLgrLZQ39C_3VnnAdCFCQOuThjy7Fn4m9szzeEvE-9yEJtFEM6OSaUsUwF5ZhCX8LlFhYlDBT-diHPL8Xyqrg6IPkUCxMv7UdKy_ibnm6HfdqJaNKwwjDBkVZT3SNHSNUOun20WCxXy3lnBTnPKyHGCJmUV3dU_m0VimT9dyHMP05H46Jz-og8HNEiXQz9e0wOQvOE3B_yR14_JTfrk3XOYvAHAEfa73-0HXVnixXtwemG9nY0NB5jrLagZnS1_npxRjGSYdiHpX1LuyEXfaDjlVQcEyiMCXKgS9Q0Hp5-w4bGNzGcpL-mm4Zu8UoHdag23TNyeXqy_nLOxtwKzImq6AFUp3WWuuBlrgyYIffBi6C8MxIp43KupE295-A_1dZxA2_yYFUoZWpLm1n-nBw2bRNeEmqMD5U3RcnrVNjCAQQVVnIbiiqAu8ITkk1jrd1IPI75L7Y6HoDzSg_zo2F-dJwfrRLyYa7zc6Dd-Kf0Z5zCWRIps2NB233XowppWUsAd6kpM1OAT6oqXtegK94K63le1Ak5nhRAj3a807lCRj0JblxC3s2vwQLxWMU0od1HGUyak1Ug82JQnLknyH9YAghPyMdJk341_vcPevV_4q_JgxywVtwZEsfksO_24Q1gpd6-HY3jFnuQDXM
  priority: 102
  providerName: Springer Nature
Title TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
URI https://link.springer.com/article/10.1038/s41467-023-43743-9
https://www.ncbi.nlm.nih.gov/pubmed/38177099
https://www.proquest.com/docview/2910046550
https://www.proquest.com/docview/2911843180
https://doaj.org/article/6f66000a71a5448983ff003db4bd325f
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELb2ISQuiDeBpTISNwgksePEB4S6Vdul0laItlJvll9BlUqym6YS_Qn8a8ZOWoQonDgkkRzHSjIzmW_szHwIvY4MjW0heejKyYWUSxVyy3XIXSyhEwVOySUKX0_Z1YJOlunyBO3pjroXuDka2jk-qUW9fvf9dvcRDP5DmzKev99Qb-7gfUJKXMlNforOwTNljtHguoP7_stMOAQ0tMudOX7pb_7Jl_E_hj3_WDf17mh0H93rcCTut4J_gE5s-RDdaZkld4_Qj_lwnoQ-LQQgJW6236oa63F_hhsIx2G8DbalcdlXa1BAPJt_mo6xy3FoZ2hxU-G6Zam3uPtZ1S01QKOnzoFbwrI0sDWrsB185RNNmh1elXjtfvbA2ilU_RgtRsP54CrsWBdCTfO0AbgdFXGkrWEJl2CgxFhDLTdaMldMLiGcqcgYApFVoTSRcCaxituMRSpTsSJP0FlZlfYZwlIamxuZZqSIqEo1gFOqGFE2zS0EMiRA8f5dC92VJHfMGGvhl8ZJLlr5CJCP8PIRPEBvDtfctAU5_tn70onw0NMV0_YNVf1VdLYpWMEA9kUyi2UK0SrPSVGArhhFlSFJWgToYq8AYq-gIuGu1h6DAC9Arw6nwTbdgossbbX1fRydTpxDn6et4hzuxFVGzACeB-jtXpN-Df73B3r-Px7oBbqbADbzM0n0Ap019da-BGzVqB46zZYZ7PPRuIfO-_3JbALHy-H08xdoHbBBz89a9Lxh_QTK7STg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYIL4s1CASPBCaImsfPwAaEC3Qdt99Kt1JvrV6qVlqTsZoX2J_Bn-I3MOI8KAb31sJfEazmez55vPJ4ZQt6ElkeuUCLAdHIBF0oHwgkTCLQlTKxBKWGg8NE0HZ_wr6fJ6Rb51cXC4LXKbk_0G7WtDJ6R78YCc5ulQKg_XnwPsGoUele7EhoNLA7c5geYbKsPky8g37dxPNyffR4HbVWBwPA8qYFOhkUUGmfTWCgAILPOciesUSkmS4uZSHVoLQPLodCGKXgTOy1cloY605Fm0O8NcpMz0OQYmT4c9Wc6mG0957yNzQlZvrvificCxRhwhtlAxR_6z5cJ-Be3_csv69Xd8B652_JUutcA6z7ZcuUDcqupXLl5SH7O9mdx4MNOgLLSev2tWlIz2jumNcwZ9LeirrQY3bUAgNPj2WQ6ohhD0ZwA07qiS3eOpcMcbS_DoisDHvrSPDAkqkoLv3oeNJ3PfSBLvaHzki7wMgk1CNjlI3JyLfP_mGyXVemeEqqUdblVScaKkOvEAPnlOmXaJbkDQ4kNSNTNtTRtynOsvLGQ3vXOctnIR4J8pJePFAPyrv_PRZPw48rWn1CEfUtM1u0fVMtz2a59mRYp0MpQZZFKwBoWOSsKwIrVXFsWJ8WA7HQAkO0OspKXeB-Q1_1rWPvo0FGlq9a-DZbriXJo86QBTj8SzLyYAf0fkPcdki47__8HPbt6LK_I7fHs6FAeTqYHz8mdGBieP4_iO2S7Xq7dC2BotX7plwUlZ9e9Dn8Dst9MEA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKViAuiDcLBYwEJ4iaxM7DB4RautsuhVVFt1Jvrl-pVlqSspsV2p_AX-LXMeMkWyGgtx5ySRzLyXwez3g83xDyOrQ8coUSAdLJBVwoHQgnTCDQlzCxhkUJE4W_jNODE_7pNDndIL-6XBg8VtnpRK-obWVwj3w7FshtliKrdtEeizjaG364-B5gBSmMtHblNBqIHLrVD3DfFu9HeyDrN3E8HEw-HgRthYHA8DypwbQMiyg0zqaxUABGZp3lTlijUiROi5lIdWgtAy-i0IYpeBI7LVyWhjrTkWbQ7w2ymaFX1CObu4Px0df1Dg9yr-ect5k6Icu3F9zrJVgmA86QG1T8sRr6ogH_snT_itL6xW94l9xprVa608DsHtlw5X1ys6ljuXpAfk4GkzjwSShgwNJ6-a2aU7O_c0xr-GvQ34K60mKu1wzgTo8no_E-xYyKZj-Y1hWdu3MsJOZoezQWAxtw0xfqgSFRVVq46mnQdD71aS31ik5LOsOjJdQgfOcPycm1SOAR6ZVV6Z4QqpR1uVVJxoqQ68SAKcx1yrRLcgduE-uTqPvX0rQE6FiHYyZ9IJ7lspGPBPlILx8p-uTt-p2Lhv7jyta7KMJ1S6Tu9jeq-blsNYFMixSMzFBlkUrANxY5KwrAitVcWxYnRZ9sdQCQrT5ZyEv098mr9WPQBBjeUaWrlr4NFu-JcmjzuAHOeiTIw5iBM9An7zokXXb-_w96evVYXpJbMAfl59H48Bm5HYO55zen-Bbp1fOlew7mWq1ftPOCkrPrnoq_Ace0UaI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TET2-mediated+tumor+cGAS+triggers+endothelial+STING+activation+to+regulate+vasculature+remodeling+and+anti-tumor+immunity+in+liver+cancer&rft.jtitle=Nature+communications&rft.au=Hongwei+Lv&rft.au=Qianni+Zong&rft.au=Cian+Chen&rft.au=Guishuai+Lv&rft.date=2024-01-04&rft.pub=Nature+Portfolio&rft.eissn=2041-1723&rft.volume=15&rft.issue=1&rft.spage=1&rft.epage=21&rft_id=info:doi/10.1038%2Fs41467-023-43743-9&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_6f66000a71a5448983ff003db4bd325f
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon